MA26816A1 - Derives d'amino-triazolopyridine - Google Patents

Derives d'amino-triazolopyridine

Info

Publication number: MA26816A1
Authority: MA; Morocco
Prior art keywords: amino; triazolopyridine derivatives; triazolopyridine; derivatives
Prior art date: 1999-09-06

Application number

MA26540A

Other languages

English (en)

Inventor

Trottmann Gerda Huber

Roland Jakob-Roetne

Matthias Heinrich Nettekoven

Claus Riemer

Walter Hunkeler

Gavin John Kilpatrick

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-06

Filing date

2002-03-06

Publication date

2004-12-20

2002-03-06 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2004-12-20 Publication of MA26816A1 publication Critical patent/MA26816A1/fr

Links

KGUHUVQIJHGHLX-UHFFFAOYSA-N 2h-triazolo[4,5-b]pyridin-5-amine Chemical class NC1=CC=C2NN=NC2=N1 KGUHUVQIJHGHLX-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Psychology (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Anesthesiology (AREA)
Hospice & Palliative Care (AREA)
Heart & Thoracic Surgery (AREA)
Addiction (AREA)
Immunology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pyridine Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

MA26540A 1999-09-06 2002-03-06 Derives d'amino-triazolopyridine MA26816A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP99117578		1999-09-06

Publications (1)

Publication Number	Publication Date
MA26816A1 true MA26816A1 (fr)	2004-12-20

Family

ID=8238933

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA26540A MA26816A1 (fr)	1999-09-06	2002-03-06	Derives d'amino-triazolopyridine

Country Status (22)

Country	Link
US (1)	US6355653B1 (fr)
EP (1)	EP1214322A2 (fr)
JP (1)	JP2003528811A (fr)
KR (1)	KR20020027625A (fr)
CN (1)	CN1379777A (fr)
AR (1)	AR037484A1 (fr)
AU (1)	AU7511000A (fr)
BR (1)	BR0013792A (fr)
CA (1)	CA2383998A1 (fr)
CZ (1)	CZ20021220A3 (fr)
HR (1)	HRP20020172A2 (fr)
HU (1)	HUP0203316A3 (fr)
IL (1)	IL148167A0 (fr)
MA (1)	MA26816A1 (fr)
MX (1)	MXPA02001748A (fr)
NO (1)	NO20021077L (fr)
PE (1)	PE20010629A1 (fr)
PL (1)	PL354240A1 (fr)
TR (1)	TR200200579T2 (fr)
WO (1)	WO2001017999A2 (fr)
YU (1)	YU13502A (fr)
ZA (1)	ZA200201055B (fr)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6506772B1 (en) *	2000-12-15	2003-01-14	Hoffmann-La Roche Inc.	Substituted [1,2,4]triazolo[1,5a]pyridine derivatives with activity as adenosine receptor ligands
US6514989B1 (en) *	2001-07-20	2003-02-04	Hoffmann-La Roche Inc.	Aromatic and heteroaromatic substituted 1,2,4-triazolo pyridine derivatives
US6693116B2 (en)	2001-10-08	2004-02-17	Hoffmann-La Roche Inc.	Adenosine receptor ligands
CA2462806A1 (fr)	2001-10-08	2003-04-17	F. Hoffmann-La Roche Ag	Amide d'acide 8-amino-[1,2,4]triazolo[1,5-a]pyridine-6-carboxylique
IL161573A0 (en)	2001-11-30	2004-09-27	Schering Corp	[1,2,4]-TRIAZOLE BICYCLIC ADENOSINE A2a RECEPTOR ANTAGONISTS
HUP0105407A3 (en) *	2001-12-21	2004-04-28	Sanofi Aventis	Triazolo[1,5-a]quinolin derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates
BR0306919A (pt)	2002-01-28	2004-11-09	Kyowa Hakko Kogyo Kk	Métodos para reduzir ou suprimir a efetividade adversa da terapia de l-dopa e/ou do agonista da dopamina, e para tratamento moderado de l-dopa, composição para tratamento moderado de l-dopa, método para tratar doença de parkinson e/ou complicações motoras de l-dopa, composição para o tratamento da doença de parkinson, e, métodos para prolongar o tratamento eficaz da doença de parkinson, e para tratar os distúrbios de movimento
EP1560818A1 (fr) *	2002-06-13	2005-08-10	Pfizer Inc.	Agents anti-gnrh non peptidiques, compositions pharmaceutiques et procedes d'utilisation
WO2005070927A2 (fr) *	2004-01-26	2005-08-04	Altana Pharma Ag	1,2,4-triazolo[1,5-a]pyridines
WO2006068954A2 (fr) *	2004-12-21	2006-06-29	Schering Corporation	Antagonistes de recepteur a2a de pyrazolo [1,5-a]pyrimidine adenosine
ES2273599B1 (es)	2005-10-14	2008-06-01	Universidad De Barcelona	Compuestos para el tratamiento de la fibrilacion auricular.
CA2657247A1 (fr) *	2006-07-28	2008-01-31	Boehringer Ingelheim International Gmbh	Composes modulant le recepteur cb2
WO2008039645A1 (fr) *	2006-09-25	2008-04-03	Boehringer Ingelheim International Gmbh	Composés modulant le recepteur cb2
EP2096923B1 (fr) *	2006-11-27	2014-01-22	H. Lundbeck A/S	Dérivés d'hétéroaryl-amides
JP2010511018A (ja) *	2006-12-01	2010-04-08	ガラパゴス・ナムローゼ・フェンノートシャップ	変性疾患及び炎症性疾患の治療に有用なトリアゾロピリジン化合物
CN101772498A (zh) *	2007-04-10	2010-07-07	H.隆德贝克有限公司	作为p2x7拮抗剂的杂芳基酰胺类似物
WO2009017954A1 (fr) *	2007-08-01	2009-02-05	Phenomix Corporation	Inhibiteurs de kinase jak2
GB0719803D0 (en)	2007-10-10	2007-11-21	Cancer Rec Tech Ltd	Therapeutic compounds and their use
CA2704684A1 (fr) *	2007-11-07	2009-05-14	Boehringer Ingelheim International Gmbh	Composes modulant le recepteur cb2
US20120015988A1 (en) *	2008-05-13	2012-01-19	Boehringer Ingelheim International Gmbh	Sulfone Compounds Which Modulate The CB2 Receptor
RU2560153C2 (ru) *	2008-06-20	2015-08-20	Дженентек, Инк.	Триазолпиридиновые соединения, ингибирующие jak, и способы
AU2009259867A1 (en)	2008-06-20	2009-12-23	Genentech, Inc.	Triazolopyridine JAK inhibitor compounds and methods
CA2730037A1 (fr) *	2008-07-10	2010-01-14	Boehringer Ingelheim International Gmbh	Composes sulfones qui modulent le recepteur cb2
TWI453207B (zh) *	2008-09-08	2014-09-21	Signal Pharm Llc	胺基三唑并吡啶，其組合物及使用其之治療方法
KR20110063485A (ko) *	2008-09-25	2011-06-10	베링거 인겔하임 인터내셔날 게엠베하	Ｃｂ2 수용체를 선택적으로 조절하는 설포닐 화합물
MY153913A (en) *	2009-05-12	2015-04-15	Janssen Pharmaceuticals Inc	7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
MX2011012961A (es)	2009-06-05	2012-01-30	Cephalon Inc	Preparacion y usos de derivados de 1,2,4-triazolo[1,5a]-piridina.
US8299103B2 (en)	2009-06-15	2012-10-30	Boehringer Ingelheim International Gmbh	Compounds which selectively modulate the CB2 receptor
JP5756800B2 (ja)	2009-06-16	2015-07-29	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Ｃｂ２受容体を調節するアゼチジン２−カルボキサミド誘導体
PT2455381E (pt) *	2009-07-17	2014-06-24	Japan Tobacco Inc	Composto de triazolopiridina e sua acção como inibidor da prolil-hidroxilase e indutor da produção de eritropoietina
WO2011037795A1 (fr) *	2009-09-22	2011-03-31	Boehringer Ingelheim International Gmbh	Composés à modulation sélective du récepteur cb2
WO2011088015A1 (fr)	2010-01-15	2011-07-21	Boehringer Ingelheim International Gmbh	Composés qui modulent le récepteur cb2
JP5746228B2 (ja)	2010-03-05	2015-07-08	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Ｃｂ２受容体を選択的に調節するテトラゾール化合物
US8846936B2 (en)	2010-07-22	2014-09-30	Boehringer Ingelheim International Gmbh	Sulfonyl compounds which modulate the CB2 receptor
PE20141553A1 (es) *	2011-09-19	2014-10-30	Hoffmann La Roche	Compuestos de triazolopiridina como inhibidores de la ped10a
EP2757882B1 (fr)	2011-09-22	2020-11-04	Merck Sharp & Dohme Corp.	Composés imidazopyridyliques utilisables en tant qu'inhibiteurs de l'aldostérone synthase
EP2757883B1 (fr)	2011-09-22	2021-01-13	Merck Sharp & Dohme Corp.	Composés triazolopyridyle à utiliser en tant qu'inhibiteurs de l'aldostérone synthase
EP2803668A1 (fr)	2013-05-17	2014-11-19	Boehringer Ingelheim International Gmbh	Nouveau (cyano-dimethyl-methyl)-isoxazoles et - [1,3,4] thiadiazoles
BR112018068681A2 (pt)	2016-03-16	2019-01-15	Bayer Cropscience Ag	derivados de n-(cianobenzil)-6-(ciclopropil-carbonilamino)-4-(fenil)-piridina-2-carboxamida e compostos relacionados como pesticidas e agentes de proteção de plantas
CN106543175B (zh) *	2016-10-28	2018-06-01	上海大学	三芳基[1,2,4]三氮唑[1,5-a]吡啶衍生物及其制备方法
RU2764655C2 (ru) *	2017-03-16	2022-01-19	Цзянсу Хэнжуй Медицин Ко., Лтд.	ПРОИЗВОДНОЕ ГЕТЕРОАРИЛ[4,3-с]ПИРИМИДИН-5-АМИНА, СПОСОБ ЕГО ПОЛУЧЕНИЯ И ЕГО МЕДИЦИНСКИЕ ПРИМЕНЕНИЯ
US20190292188A1 (en)	2018-02-27	2019-09-26	Incyte Corporation	Imidazopyrimidines and triazolopyrimidines as a2a / a2b inhibitors
MA52940A (fr)	2018-05-18	2021-04-28	Incyte Corp	Dérivés de pyrimidine fusionnés utilisés en tant qu'inhibiteurs de a2a/a2b
CN113166153B (zh)	2018-07-05	2024-11-01	因赛特公司	作为a2a/a2b抑制剂的稠合吡嗪衍生物
WO2020054712A1 (fr) *	2018-09-12	2020-03-19	日本化薬株式会社	Agent de lutte contre les organismes nuisibles
KR20210116488A (ko)	2018-12-20	2021-09-27	인사이트 코포레이션	액티빈 수용체-유사 키나제-2의 억제제로서의 이미다조피리다진 및 이미다조피리딘 화합물
TWI829857B (zh)	2019-01-29	2024-01-21	美商英塞特公司	作為a2a / a2b抑制劑之吡唑并吡啶及三唑并吡啶
CN115867553B (zh) *	2021-01-09	2026-03-06	巴格沃克斯研究有限公司	作为腺苷2A受体和腺苷2B受体拮抗剂的二氨基吡唑[1, 5-a]并嘧啶-6-腈化合物
CN116082335B (zh) *	2023-01-16	2026-02-24	上海凌凯科技股份有限公司	一种二芳基醚化合物的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9226735D0 (en)	1992-12-22	1993-02-17	Ici Plc	Azole derivatives
AU2639299A (en)	1998-02-24	1999-09-15	Kyowa Hakko Kogyo Co. Ltd.	Remedies/preventives for parkinson's disease

2000
- 2000-08-24 US US09/645,127 patent/US6355653B1/en not_active Expired - Fee Related
- 2000-08-28 WO PCT/EP2000/008372 patent/WO2001017999A2/fr not_active Ceased
- 2000-08-28 MX MXPA02001748A patent/MXPA02001748A/es unknown
- 2000-08-28 HU HU0203316A patent/HUP0203316A3/hu unknown
- 2000-08-28 TR TR2002/00579T patent/TR200200579T2/xx unknown
- 2000-08-28 CN CN00812501A patent/CN1379777A/zh active Pending
- 2000-08-28 PL PL00354240A patent/PL354240A1/xx not_active Application Discontinuation
- 2000-08-28 JP JP2001522222A patent/JP2003528811A/ja active Pending
- 2000-08-28 IL IL14816700A patent/IL148167A0/xx unknown
- 2000-08-28 HR HR20020172A patent/HRP20020172A2/hr not_active Application Discontinuation
- 2000-08-28 CZ CZ20021220A patent/CZ20021220A3/cs unknown
- 2000-08-28 EP EP00964043A patent/EP1214322A2/fr not_active Withdrawn
- 2000-08-28 KR KR1020027002990A patent/KR20020027625A/ko not_active Ceased
- 2000-08-28 AU AU75110/00A patent/AU7511000A/en not_active Abandoned
- 2000-08-28 CA CA002383998A patent/CA2383998A1/fr not_active Abandoned
- 2000-08-28 YU YU13502A patent/YU13502A/sh unknown
- 2000-08-28 BR BR0013792-8A patent/BR0013792A/pt not_active IP Right Cessation
- 2000-09-04 PE PE2000000903A patent/PE20010629A1/es not_active Application Discontinuation
- 2000-09-04 AR ARP000104612A patent/AR037484A1/es not_active Application Discontinuation
2002
- 2002-02-06 ZA ZA200201055A patent/ZA200201055B/xx unknown
- 2002-03-05 NO NO20021077A patent/NO20021077L/no not_active Application Discontinuation
- 2002-03-06 MA MA26540A patent/MA26816A1/fr unknown

Also Published As

Publication number	Publication date
CA2383998A1 (fr)	2001-03-15
IL148167A0 (en)	2002-09-12
HUP0203316A3 (en)	2004-07-28
AR037484A1 (es)	2004-11-17
BR0013792A (pt)	2002-05-14
WO2001017999A2 (fr)	2001-03-15
US6355653B1 (en)	2002-03-12
EP1214322A2 (fr)	2002-06-19
PL354240A1 (en)	2003-12-29
CN1379777A (zh)	2002-11-13
CZ20021220A3 (cs)	2002-10-16
TR200200579T2 (tr)	2002-12-23
NO20021077D0 (no)	2002-03-05
NO20021077L (no)	2002-03-05
PE20010629A1 (es)	2001-05-30
YU13502A (sh)	2004-11-25
HUP0203316A2 (hu)	2003-01-28
HRP20020172A2 (en)	2003-10-31
WO2001017999A3 (fr)	2001-12-06
ZA200201055B (en)	2003-07-30
AU7511000A (en)	2001-04-10
JP2003528811A (ja)	2003-09-30
KR20020027625A (ko)	2002-04-13
MXPA02001748A (es)	2002-08-06

Publication	Publication Date	Title
MA26816A1 (fr)	2004-12-20	Derives d'amino-triazolopyridine
MA26831A1 (fr)	2004-12-20	Derives de benzodiazepine."
NO20000885L (no)	2000-08-25	4-Fenyl-pyridin-derivater
DE60009747D1 (de)	2004-05-13	Admantan-derivate
ATE293104T1 (de)	2005-04-15	Thiazolylamid-derivate
IS6128A (is)	2001-10-26	13-Metýl-erýþrómýsín afleiður
DK1187814T3 (da)	2004-12-20	5-phenyl-pyrimidinderivater
NO20021803L (no)	2002-06-17	Isoksazolkarboksamid-derivater
ATE257148T1 (de)	2004-01-15	Propargyletherderivate
DK1154988T3 (da)	2004-11-22	Mevinolinderivater
ATE374747T1 (de)	2007-10-15	Monofluoralkylderivate
ATE293592T1 (de)	2005-05-15	Resorcinderivate
DE60006703D1 (de)	2003-12-24	4-hydroxybiphenylhydrazid-derivate
DK1187815T3 (da)	2006-06-19	4-phenyl-pyrimidinderivater
TR200002831A3 (tr)	2001-04-20	Kinolin-4-Il türevleri I
DK1189886T3 (da)	2006-05-15	Ethansulfonyl-piperidinderivater
MA27240A1 (fr)	2005-03-01	Derives d'imidazoquinoleine
NO20020212L (no)	2002-01-15	3-amino-2-benzyl-1-fenyl-propanderivater
NO20022867D0 (no)	2002-06-14	Syklopentenon-derivater
PT1060183E (pt)	2003-08-29	Derivados de 5'-desoxicitidina
DK1178984T3 (da)	2003-06-10	1-trifluormethyl-4-hydroxy-7-piperidinylaminomethylchroman-derivater
EP1192168A4 (fr)	2003-04-16	Galectine 11
ATE243218T1 (de)	2003-07-15	2''-deoxyhygromycinderivate
DE59909774D1 (de)	2004-07-22	1-cycloalkylpyrazolyl-benzoyl-derivate
MA26481A1 (fr)	2004-12-20	Derives d'arylsecocholadiene